Human SARS-coronavirus RNA-dependent RNA polymerase: activity determinants and nucleoside analogue inhibitors.
Azzi
Arezki
A
Molecular Endocrinology and Oncology Research Center, Laval University Medical Center (CHUL). Québec City, Canada.
Lin
Sheng-Xiang
SX
D020816:Amino Acid Motifs; D020134:Catalytic Domain; D017124:Conserved Sequence; D017929:Hemorrhagic Disease Virus, Rabbit / Q000201:enzymology; D008024:Ligands; D008958:Models, Molecular; D009705:Nucleosides / Q000378:metabolism / Q000494:pharmacology*; D017433:Protein Structure, Secondary; D012324:RNA-Dependent RNA Polymerase / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D045473:Severe acute respiratory syndrome-related coronavirus / Q000201:enzymology*; D017386:Sequence Homology, Amino Acid; D013816:Thermodynamics; D014544:Uridine Triphosphate / Q000378:metabolism
D008024:Ligands; D009705:Nucleosides; D012324:RNA-Dependent RNA Polymerase; D014544:Uridine Triphosphate